Influenza Vaccine Market Trends, Growth Analysis, Investigation by Regions, Types, Applications and Analysis of Key Players

The QY Research released a latest market research report on the Global Influenza Vaccine market, which is segmented by region (country), company, by Purity, and by Application. Players, stakeholders, and other participants in the global Influenza Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country) and by Application for the period 2017-2028.

For More Information About This Report, Please Enter:
https://us.qyresearch.com/reports/348203/influenza-vaccine

Summary
Market Analysis and Insights: Global Influenza Vaccine Market
Due to the COVID-19 pandemic, the global Influenza Vaccine market size is estimated to be worth US$ 8036 million in 2022 and is forecast to a readjusted size of US$ 10952 million by 2028 with a CAGR of 5.3% during the review period.

Influenza Vaccine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Influenza Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type, and by Application for the period 2017-2028.

By Company
Sanofi
CSL
GSK
Viatris
AstraZeneca
Hualan Bio
Changchun Institute of Biological
Sinovac
BCHT
Jiangsu GDK
KM Biologics

Segment by Type
Trivalent Influenza Vaccine
Quadrivalent Influenza Vaccine


Segment by Application
For Children (6 months to 3 years)
For Adults and Children over 3 years


Segment by Region
North America
U.S.
Canada
Mexico

Asia-Pacific
China
Japan
South Korea
India
Australia
Southeast Asia

Europe
Germany
France
U.K.
Italy
Russia

South America
Brazil

Middle East & Africa
Middle East
Africa

The Goal of the Report
1.To study and analyze the global Influenza Vaccine consumption (value & volume) by key regions/countries, type and application, history data from 2017 to 2022, and forecast to 2028.
2.To understand the structure of Influenza Vaccine market by identifying its various subsegments.
3.Focuses on the key global Influenza Vaccine manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
4.To analyze the Influenza Vaccine with respect to individual growth trends, prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges, and risks).
6.To project the consumption of Influenza Vaccine submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.

Target Audience
> Influenza Vaccine companies
> Research organizations
> Government Organizations
> Research/Consultancy firms

Table of Contents
1 STUDY COVERAGE 1
1.1 Influenza Vaccine Product Introduction 1
1.2 Market by Type 1
1.2.1 Global Influenza Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1
1.2.2 Trivalent Influenza Vaccine 3
1.2.3 Quadrivalent Influenza Vaccine 4
1.3 Market by Application 5
1.3.1 Global Influenza Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 5
1.3.2 For Children (6 months to 3 years) 7
1.3.3 For Adults and Children over 3 years 8
1.4 Study Objectives 8
1.5 Years Considered 9
2 EXECUTIVE SUMMARY 10
2.1 Global Influenza Vaccine Sales Estimates and Forecasts 2017-2028 10
2.2 Global Influenza Vaccine Revenue Estimates and Forecasts 2017-2028 11
2.3 Global Influenza Vaccine Revenue by Region: 2017 VS 2021 VS 2028 12
2.4 Global Influenza Vaccine Sales by Region 14
2.4.1 Global Influenza Vaccine Sales by Region (2017-2022) 14
2.4.2 Global Sales Influenza Vaccine by Region (2023-2028) 15
2.5 Global Influenza Vaccine Revenue by Region 16
2.5.1 Global Influenza Vaccine Revenue by Region (2017-2022) 16
2.5.2 Global Influenza Vaccine Revenue by Region (2023-2028) 17
2.6 North America 18
2.7 Europe 19
2.8 Asia-Pacific 20
2.9 South America 21
2.10 Middle East & Africa 22
3 COMPETITION BY MANUFACTURERS 23
3.1 Global Influenza Vaccine Sales by Manufacturers 23
3.1.1 Global Influenza Vaccine Sales by Manufacturers (2020-2022) 23
3.1.2 Global Influenza Vaccine Sales Market Share by Manufacturers (2020-2022) 24
3.1.3 Global Top Largest Manufacturers of Influenza Vaccine in 2021 24
3.2 Global Influenza Vaccine Revenue by Manufacturers 25
3.2.1 Global Influenza Vaccine Revenue by Manufacturers (2020-2022) 25
3.2.2 Global Influenza Vaccine Revenue Market Share by Manufacturers (2020-2022) 26
3.2.3 Global Top Companies by Influenza Vaccine Revenue in 2021 27
3.3 Global Influenza Vaccine Sales Price by Manufacturers (2020-2022) 27
3.4 Analysis of Competitive Landscape 28
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 28
3.4.2 Global Influenza Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) 29
3.4.3 Global Influenza Vaccine Manufacturers Geographical Distribution 30
3.5 Mergers & Acquisitions, Expansion Plans 31
4 MARKET SIZE BY TYPE 35
4.1 Global Influenza Vaccine Sales by Type 35
4.1.1 Global Influenza Vaccine Historical Sales by Type (2017-2022) 35
4.1.2 Global Influenza Vaccine Forecasted Sales by Type (2023-2028) 35
4.1.3 Global Influenza Vaccine Sales Market Share by Type (2017-2028) 35
4.2 Global Influenza Vaccine Revenue by Type 36
4.2.1 Global Influenza Vaccine Historical Revenue by Type (2017-2022) 36
4.2.2 Global Influenza Vaccine Forecasted Revenue by Type (2023-2028) 37
4.2.3 Global Influenza Vaccine Revenue Market Share by Type (2017-2028) 37
4.3 Global Influenza Vaccine Price by Type 38
4.3.1 Global Influenza Vaccine Price by Type (2017-2022) 38
4.3.2 Global Influenza Vaccine Price Forecast by Type (2023-2028) 38
5 MARKET SIZE BY APPLICATION 39
5.1 Global Influenza Vaccine Sales by Application 39
5.1.1 Global Influenza Vaccine Historical Sales by Application (2017-2022) 39
5.1.2 Global Influenza Vaccine Forecasted Sales by Application (2023-2028) 39
5.1.3 Global Influenza Vaccine Sales Market Share by Application (2017-2028) 39
5.2 Global Influenza Vaccine Revenue by Application 40
5.2.1 Global Influenza Vaccine Historical Revenue by Application (2017-2022) 40
5.2.2 Global Influenza Vaccine Forecasted Revenue by Application (2023-2028) 41
5.2.3 Global Influenza Vaccine Revenue Market Share by Application (2017-2028) 41
5.3 Global Influenza Vaccine Price by Application 42
5.3.1 Global Influenza Vaccine Price by Application (2017-2022) 42
5.3.2 Global Influenza Vaccine Price Forecast by Application (2023-2028) 42
6 NORTH AMERICA 43
6.1 North America Influenza Vaccine Market Size by Type 43
6.1.1 North America Influenza Vaccine Sales by Type (2017-2028) 43
6.1.2 North America Influenza Vaccine Revenue by Type (2017-2028) 44
6.2 North America Influenza Vaccine Market Size by Application 45
6.3 North America Influenza Vaccine Sales by Country 46
6.3.1 North America Influenza Vaccine Sales by Country (2017-2028) 46
6.3.2 North America Influenza Vaccine Revenue by Country (2017-2028) 47
6.3.3 U.S. 48
6.3.4 Canada 48
6.3.5 Mexico 49
7 EUROPE 50
7.1 Europe Influenza Vaccine Market Size by Type 50
7.1.1 Europe Influenza Vaccine Sales by Type (2017-2028) 50
7.1.2 Europe Influenza Vaccine Revenue by Type (2017-2028) 51
7.2 Europe Influenza Vaccine Market Size by Application 52
7.3 Europe Influenza Vaccine Market Size by Country 53
7.3.1 Europe Influenza Vaccine Sales by Country (2017-2028) 53
7.3.2 Europe Influenza Vaccine Revenue by Country (2017-2028) 54
7.3.3 Germany 55
7.3.4 France 56
7.3.5 U.K. 56
7.3.6 Italy 57
7.3.7 Russia 57
8 ASIA PACIFIC 58
8.1 Asia Pacific Influenza Vaccine Market Size by Type 58
8.1.1 Asia Pacific Influenza Vaccine Sales by Type (2017-2028) 58
8.1.2 Asia Pacific Influenza Vaccine Revenue by Type (2017-2028) 59
8.2 Asia Pacific Influenza Vaccine Market Size by Application 60
8.3 Asia Pacific Influenza Vaccine Market Size by Region 61
8.3.1 Asia Pacific Influenza Vaccine Sales by Region (2017-2028) 61
8.3.2 Asia Pacific Influenza Vaccine Revenue by Region (2017-2028) 62
8.3.3 China 64
8.3.4 Japan 64
8.3.5 South Korea 65
8.3.6 India 65
8.3.7 Australia 66
8.3.8 Southeast Asia 66
9 SOUTH AMERICA 67
9.1 South America Influenza Vaccine Market Size by Type 67
9.1.1 South America Influenza Vaccine Sales by Type (2017-2028) 67
9.1.2 South America Influenza Vaccine Revenue by Type (2017-2028) 68
9.2 South America Influenza Vaccine Market Size by Application 69
9.3 South America Influenza Vaccine Market Size by Country 70
9.3.1 South America Influenza Vaccine Sales by Country (2017-2028) 70
9.3.2 South America Influenza Vaccine Revenue by Country (2017-2028) 71
9.3.3 Brazil 72
10 MIDDLE EAST AND AFRICA 73
10.1 Middle East and Africa Influenza Vaccine Market Size by Type 73
10.1.1 Middle East and Africa Influenza Vaccine Sales by Type (2017-2028) 73
10.1.2 Middle East and Africa Influenza Vaccine Revenue by Type (2017-2028) 74
10.2 Middle East and Africa Influenza Vaccine Market Size by Application 75
10.3 Middle East and Africa Influenza Vaccine Market Size by Country 76
10.3.1 Middle East and Africa Influenza Vaccine Sales by Country (2017-2028) 76
10.3.2 Middle East and Africa Influenza Vaccine Revenue by Country (2017-2028) 77
10.3.3 Middle East 79
10.3.4 Africa 79
11 CORPORATE PROFILE 80
11.1 Sanofi 80
11.1.1 Sanofi Corporation Information 80
11.1.2 Sanofi Overview 80
11.1.3 Sanofi Influenza Vaccine Sales, Price, Revenue and Gross Margin (2020-2022) 81
11.1.4 Sanofi Influenza Vaccine Product Introduction 81
11.1.5 Sanofi Recent Developments 83
11.2 CSL 84
11.2.1 CSL Corporation Information 84
11.2.2 CSL Overview 84
11.2.3 CSL Influenza Vaccine Sales, Price, Revenue and Gross Margin (2020-2022) 85
11.2.4 CSL Influenza Vaccine Product Introduction 86
11.2.5 CSL Recent Developments 86
11.3 GSK 88
11.3.1 GSK Corporation Information 88
11.3.2 GSK Overview 89
11.3.3 GSK Influenza Vaccine Sales, Price, Revenue and Gross Margin (2020-2022) 89
11.3.4 GSK Influenza Vaccine Product Introduction 90
11.4 Viatris 91
11.4.1 Viatris Corporation Information 91
11.4.2 Viatris Overview 92
11.4.3 Viatris Influenza Vaccine Sales, Price, Revenue and Gross Margin (2020-2022) 92
11.4.4 Viatris Influenza Vaccine Product Introduction 93
11.4.5 Viatris Recent Developments 93
11.5 AstraZeneca 94
11.5.1 AstraZeneca Corporation Information 94
11.5.2 AstraZeneca Overview 95
11.5.3 AstraZeneca Influenza Vaccine Sales, Price, Revenue and Gross Margin (2020-2022) 95
11.5.4 AstraZeneca Influenza Vaccine Product Introduction 96
11.5.5 AstraZeneca Recent Developments 97
11.6 Hualan Bio 97
11.6.1 Hualan Bio Corporation Information 97
11.6.2 Hualan Bio Overview 98
11.6.3 Hualan Bio Influenza Vaccine Sales, Price, Revenue and Gross Margin (2020-2022) 99
11.6.4 Hualan Bio Influenza Vaccine Product Introduction 99
11.7 Changchun Institute of Biological 100
11.7.1 Changchun Institute of Biological Corporation Information 100
11.7.2 Changchun Institute of Biological Overview 101
11.7.3 Changchun Institute of Biological Influenza Vaccine Sales, Price, Revenue and Gross Margin (2020-2022) 102
11.7.4 Changchun Institute of Biological Influenza Vaccine Product Introduction 102
11.7.5 Changchun Institute of Biological Recent Developments 103
11.8 Sinovac 103
11.8.1 Sinovac Corporation Information 103
11.8.2 Sinovac Overview 104
11.8.3 Sinovac Influenza Vaccine Sales, Price, Revenue and Gross Margin (2020-2022) 104
11.8.4 Sinovac Influenza Vaccine Product Introduction 104
11.8.5 Sinovac Recent Developments 106
11.9 BCHT 106
11.9.1 BCHT Corporation Information 106
11.9.2 BCHT Overview 107
11.9.3 BCHT Influenza Vaccine Sales, Price, Revenue and Gross Margin (2020-2022) 108
11.9.4 BCHT Influenza Vaccine Product Introduction 108
11.9.5 BCHT Recent Developments 109
11.10 Jiangsu GDK 110
11.10.1 Jiangsu GDK Corporation Information 110
11.10.2 Jiangsu GDK Overview 111
11.10.3 Jiangsu GDK Influenza Vaccine Sales, Price, Revenue and Gross Margin (2020-2022) 112
11.10.4 Jiangsu GDK Influenza Vaccine Product Introduction 112
11.11 KM Biologics 113
11.11.1 KM Biologics Corporation Information 113
11.11.2 KM Biologics Overview 113
11.11.3 KM Biologics Influenza Vaccine Sales, Price, Revenue and Gross Margin (2020-2022) 115
11.11.4 KM Biologics Influenza Vaccine Product Introduction 115
11.11.5 KM Biologics Recent Developments 116
12 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS 118
12.1 Influenza Vaccine Industry Chain Analysis 118
12.2 Influenza Vaccine Key Raw Materials 119
12.2.1 Key Raw Materials 119
12.2.2 Raw Materials Key Suppliers 119
12.3 Influenza Vaccine Production Mode & Process 121
12.4 Influenza Vaccine Sales and Marketing 122
12.4.1 Influenza Vaccine Sales Channels 122
12.4.2 Influenza Vaccine Distributors 123
12.5 Influenza Vaccine Customers 125
13 INFLUENZA VACCINE MARKET DYNAMICS 129
13.1.1 Influenza Vaccine Industry Trends 129
13.1.2 Influenza Vaccine Market Drivers 130
13.1.3 Influenza Vaccine Market Challenges 131
13.1.4 Influenza Vaccine Market Restraints 131
14 KEY FINDINGS IN THE GLOBAL INFLUENZA VACCINE STUDY 132
15 APPENDIX 134
15.1 Research Methodology 134
15.1.1 Methodology/Research Approach 134
15.1.2 Data Source 137
15.2 Author Details 140

Access full Report Description, Table of Figure, Chart, FREE sample, etc. please click
https://us.qyresearch.com/reports/348203/influenza-vaccine

Any doubts and questions will be welcome.

Customization of the Report:
This report can be customized to meet the client's requirements. Please contact with us (global@qyresearch.com), who will ensure that you get a report that suits your needs.

About Us:
QYResearch founded in California, USA in 2007.It is a leading global market research and consulting company. With over 15 years' experience and professional research team in various cities over the world，QY Research focuses on management consulting, database and seminar services, IPO consulting, industry chain research and customized research to help our clients in providing non-linear revenue model and make them successful. We are globally recognized for our expansive portfolio of services, good corporate citizenship, and our strong commitment to sustainability. Up to now, we have cooperated with more than 59,000 clients across five continents. Let's work closely with you and build a bold and better future.

Contact Us
QY Research
E-mail: global@qyresearch.com
Tel: +1-626-842-1666(US) +852-5808-0956 (HK)
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
Website: https://us.qyresearch.com

The QY Research released a latest market research report on the Global Influenza Vaccine market, which is segmented by region (country), company, by Purity, and by Application. Players, stakeholders, and other participants in the global Influenza Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country) and by Application for the period 2017-2028.

QYResearch founded in California, USA in 2007.It is a leading global market research and consulting company. With over 15 years' experience and professional research team in various cities over the world，QY Research focuses on management consulting, database and seminar services, IPO consulting, industry chain research and customized research to help our clients in providing non-linear revenue model and make them successful. We are globally recognized for our expansive portfolio of services, good corporate citizenship, and our strong commitment to sustainability. Up to now, we have cooperated with more than 59,000 clients across five continents. Let's work closely with you and build a bold and better future.

This release was published on openPR.